ASKA Pharmaceutical Co., Ltd - Financial Analysis Review
Summary
ASKA Pharmaceutical Co., Ltd. (ASKA Pharmaceutical) is a Japan-based company principally engaged in manufacturing of medicines for human and animal health. The company’s product portfolio consists of peptic ulcer and gastritis agent Altat, and Prostal. ASKA Pharmaceutical operates through two business segments namely, Pharmaceutical Products and Others. The company operates through three subsidiaries and two associated companies. Its research activities are performed at its Kawasaki Research and Technical Center. ASKA Pharmaceutical also supplies medical equipment and performs three clinical stage products namely, BNP 7787, TZT-1027 and RPR106522. It principally operates in Japan.
Global Markets Direct’s "ASKA Pharmaceutical Co., Ltd - Financial Analysis Review” is an in-depth business and financial analysis of ASKA Pharmaceutical Co., Ltd. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the financial analysis of the company. This highlights the company’s ratio analysis for the past five years.
And More inside the report…
Recent Developments
Nov 02, 2009: Sosei, ASKA to Commercialise NorLevo in Japan
Jul 27, 2009: Wyeth, ASKA, Takeda Report Changes In SELTOUCH's Japanese Sales, Distribution
Scope
- Provides key company information for business intelligence needs
- The report contains critical company information – business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
- The report provides detailed financial ratios for the past five years as well as interim ratios for the last fourinterim periods.
- Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Reasons to buy
- A quick “one-stop-shop” to understand the company.
- Enhance business/sales activities by understanding customers’ businesses better.
- Get detailed information and financial analysis on companies operating in your industry.
- Identify prospective partners and suppliers – with key data on their businesses and locations.
- Compare your company’s financial trends with those of your peers / competitors.
- Scout for potential acquisition targets, with insight into the companies’ financial performance.
Report Highlights
The following companies are the major competitors of ASKA Pharmaceutical Co., Ltd:
Astellas Pharma Inc.
Nippon Shinyaku Co., Ltd.
[Cerrar las informaciones del articulo de mercado]
